Contact

Payer

Pharma

Provider

Formulary guidance and transparency from P&T to point of care

Trends that Matter for Prior Authorizations

Posted by Matt Breese on Feb 24, 2016

Find me on:

The following infographics highlight how health plans leverage PAs in trending therapeutic areas. Payers implement prior authorizations to control costs and restrict reimbursement for specific drugs. A clinical review of these utilization management strategies reveals that some plans often require PAs that are restrictive to the drug's FDA approved label.

Multiple Sclerosis: Over half of the largest payers that cover MS treatments implement PA policies. Click on the image to view more.

multiple-sclerosis-UM-PA.png

 

Cystic Fibrosis: A review of pharmacy benefit structures for CF treatments reveals that roughly 20% of lives require a prior authorization that is restrictive to the FDA approved label. Click on the image to view more.

cystic-fibrosis-UM-PA.png

 

Detoxification Agents: For alcohol deterrence products, roughly 1/3 of PAs are restrictive-to-label when present. Click on the image to view more.

detox-UM-PA.png

 

Antidepressants: Utilization management from top payers shows that PAs for roughly 44% of lives are restrictive to their label. Click on the image to view more.

antidepressant-UM-PA.png

Subscribe to the MMIT blog for more utilization management and market access trends, with perspectives from payers and providers.

Subscribe for Weekly Trends that Matter

Topics: Specialty, Industry Trends, Payer